Speciality: Hematology
Description:
A warm welcome to all the medical professionals to this highly anticipated panel discussion on "An Eagle's View - Evidence-based Discussion on Iron Deficiency Anemia." Following our in-depth look at IDA, this session offers a unique opportunity for a dynamic and interactive exchange among experts. The goal is to address the multifaceted challenges in diagnosing and treating IDA in various patient populations, from managing comorbidities to navigating treatment resistance.
This panel will delve into pressing questions that arise in clinical practice. Topics will include the most effective strategies for iron repletion in patients with chronic inflammatory conditions, such as inflammatory bowel disease, where oral iron absorption is often impaired. The experts will also discuss the optimal use of intravenous iron formulations, considering factors like dosing, patient safety, and the cost-benefit analysis in different healthcare settings. This discussion will highlight the importance of personalized, evidence-based decision-making.
Therefore, get an overall knowledge of how to apply an evidence-based approach to the complexities of iron deficiency anemia in a panel discussion format. Absorb the shared knowledge, get your questions answered by experts, and follow Hidoc for more such insightful webinar sessions.
See More Webinars @ Hidoc Webinars
1.
More Positive Survival Data in Lung Cancer With Perioperative Therapy
2.
Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy
3.
Study finds 10% of pediatric blood cancers may stem from medical imaging radiation
4.
For the creation of cutting-edge targeted radionuclide therapies in oncology, Bayer and Bicycle Therapeutics work together.
5.
Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.
1.
Case Study: Artificial Intelligence in Early Cancer Detection
2.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
3.
What is Mullerian and How Does it Affect Your Health
4.
AI in Cancer Care: Transforming Research & Treatment with Deep Learning Technologies
5.
Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Should We Use DARA Up Front As First-Line Therapy in MM?
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation